Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1677
+0.0021(+0.18%)
GBP/USD
1.2496
-0.0015(-0.12%)
Bitcoin GBP
51,228.96
-444.23(-0.86%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Relief Therapeutics Holding SA (RLFTF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

1.4500

0.0000

(0.00%)

As of 12:33PM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	16.70M
Enterprise value	6.25M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	2.46
Price/book (mrq)	0.17
Enterprise value/revenue	1.07
Enterprise value/EBITDA	-0.07

Trading information

Stock price history

Beta (5Y monthly)	-14.37
52-week change ³	7,955.56%
S&P500 52-week change ³	21.08%
52-week high ³	8.4000
52-week low ³	0.0140
50-day moving average ³	1.6037
200-day moving average ³	2.2455

Share statistics

Avg vol (3-month) ³	2.84k
Avg vol (10-day) ³	1.44k
Shares outstanding ⁵	12.22M
Implied shares outstanding ⁶	12.38M
Float ⁸	8.65M
% held by insiders ¹	0.57%
% held by institutions ¹	29.06%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:400
Last split date ³	05 May 2023

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends	31 Dec 2022
Most-recent quarter (mrq)	30 Jun 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-383.59%

Management effectiveness

Return on assets (ttm)	-9.55%
Return on equity (ttm)	-63.17%

Income statement

Revenue (ttm)	5.86M
Revenue per share (ttm)	0.54
Quarterly revenue growth (yoy)	-6.80%
Gross profit (ttm)	N/A
EBITDA	-23.46M
Net income avi to common (ttm)	-80.79M
Diluted EPS (ttm)	-8.0600
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	12.8M
Total cash per share (mrq)	1.05
Total debt (mrq)	4.55M
Total debt/equity (mrq)	4.82%
Current ratio (mrq)	2.30
Book value per share (mrq)	7.72

Cash flow statement

Operating cash flow (ttm)	-19.86M
Levered free cash flow (ttm)	-16.67M